Literature DB >> 9858597

Melanization of Cryptococcus neoformans in murine infection.

J D Nosanchuk1, P Valadon, M Feldmesser, A Casadevall.   

Abstract

Cryptococcus neoformans is a fungus that is pathogenic in humans and that can produce melanin in vitro. Melanization is associated with virulence, but there is no evidence that melanin is made during infection. Melanins are difficult to study because they are amorphous and insoluble. Melanin-binding peptides from a phage display library were used to demonstrate that C. neoformans makes melanin-like compounds in tissue. Melanin-binding peptides were characterized by a high proportion of positively charged and aromatic residues. Two other methods, demonstration of an antibody response to melanin in mice infected with C. neoformans and analysis of yeast cell walls in infected tissue by light microscopy, were used to support these findings. The demonstration that C. neoformans melanizes in tissue has important implications for pathogenesis and drug discovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9858597      PMCID: PMC83931          DOI: 10.1128/MCB.19.1.745

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans.

Authors:  Y Wang; P Aisen; A Casadevall
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B.

Authors:  Y Wang; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

4.  Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase.

Authors:  P R Williamson
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

5.  Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.

Authors:  Y Wang; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  A standardized test for the identification and characterization of melanins using electron paramagnetic resonance (EPR) spectroscopy.

Authors:  W S Enochs; M J Nilges; H M Swartz
Journal:  Pigment Cell Res       Date:  1993-03

7.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

8.  Cryptococcus neoformans melanin and virulence: mechanism of action.

Authors:  Y Wang; P Aisen; A Casadevall
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants.

Authors:  Y Wang; A Casadevall
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.

Authors:  S D Salas; J E Bennett; K J Kwon-Chung; J R Perfect; P R Williamson
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  46 in total

Review 1.  Pathogenic roles for fungal melanins.

Authors:  E S Jacobson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

4.  A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors:  Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection.

Authors:  Martha E Urán; Joshua D Nosanchuk; Angela Restrepo; Andrew J Hamilton; Beatriz L Gómez; Luz E Cano
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

6.  Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans.

Authors:  C Luberto; D L Toffaletti; E A Wills; S C Tucker; A Casadevall; J R Perfect; Y A Hannun; M Del Poeta
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

7.  Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.

Authors:  Marcio L Rodrigues; Li Shi; Eliana Barreto-Bergter; Leonardo Nimrichter; Sandra E Farias; Elaine G Rodrigues; Luiz R Travassos; Joshua D Nosanchuk
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

Review 8.  Peptide-targeted radionuclide therapy for melanoma.

Authors:  Yubin Miao; Thomas P Quinn
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-02       Impact factor: 6.312

9.  Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response.

Authors:  Yiorgos Apidianakis; Laurence G Rahme; Joseph Heitman; Frederick M Ausubel; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2004-04

10.  Fungal cell gigantism during mammalian infection.

Authors:  Oscar Zaragoza; Rocío García-Rodas; Joshua D Nosanchuk; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.